{"ok":true,"province":"aga","name":"AGA（薄毛）治療の選び方","name_en":"Hair-loss (AGA) Treatment Selector","level":1,"criteria":[{"id":"aga_evidence","label":"エビデンス（学会の推奨度）","label_en":"Evidence / guideline grade","direction":"higher","description":"日本皮膚科学会ガイドラインの推奨度（A〜D）が高いほど高評価。科学的根拠の強さ。","unit":"score","kind":"fact"},{"id":"aga_efficacy","label":"発毛・維持の効果","label_en":"Efficacy","direction":"higher","description":"抜け毛を止め、髪を増やす・維持する効果が大きいほど高評価。","unit":"score","kind":"editorial"},{"id":"aga_safety","label":"副作用の少なさ・安全性","label_en":"Safety","direction":"higher","description":"副作用が少なく、長く安全に続けられるほど高評価。","unit":"score","kind":"editorial"},{"id":"aga_cost","label":"費用の軽さ（コスパ）","label_en":"Affordability","direction":"higher","description":"月々・総額の費用が安く続けやすいほど高評価。AGAは自由診療で全額自己負担。","unit":"score","kind":"editorial"},{"id":"aga_keep","label":"続けやすさ（手軽さ・通院負担）","label_en":"Ease of adherence","direction":"higher","description":"手間や通院負担が少なく、生活に組み込みやすいほど高評価。","unit":"score","kind":"editorial"}],"items":[{"id":"aga_fin","name":"フィナステリド内服","name_en":null,"provider":"内服薬","jurisdiction":"日本","note":"5α還元酵素II型を阻害しDHTを抑える内服薬。男性の推奨度A。ジェネリックが普及し費用も下がった。","note_en":null,"url":"https://www.jstage.jst.go.jp/article/dermatol/127/13/127_2763/_article/-char/ja/","shop_url":null,"metrics":{"aga_evidence":95,"aga_efficacy":78,"aga_safety":75,"aga_cost":80,"aga_keep":88},"facts":[{"label":"エビデンス（学会の推奨度）","text":"A","source":"日本皮膚科学会GL2017：推奨度A"}],"sources":{"aga_evidence":"日本皮膚科学会GL2017：推奨度A","aga_efficacy":"editorial: 還元酵素のII型を阻害してDHTを抑える仕組みの内服薬で、この軸は候補の中ほどのためやや高め（2026-06初評）","aga_safety":"editorial: ホルモンに関わる酵素を抑える内服薬で作用が全身に及ぶ型のため、候補の中ほどに置きやや高め（2026-06初評）","aga_cost":"editorial: ジェネリックが普及して薬代が下がった内服薬で、費用の軽さは候補8つで最上位のため高め（2026-06初評）","aga_keep":"editorial: 一日一回飲むだけで生活に組み込みやすく、続けやすさはデュタステリドと並ぶ上位のため高め（2026-06初評）"}},{"id":"aga_dut","name":"デュタステリド内服","name_en":null,"provider":"内服薬","jurisdiction":"日本","note":"5α還元酵素I型・II型の両方を阻害。フィナステリドより強力な傾向。男性の推奨度A。","note_en":null,"url":"https://www.jstage.jst.go.jp/article/dermatol/127/13/127_2763/_article/-char/ja/","shop_url":null,"metrics":{"aga_evidence":95,"aga_efficacy":85,"aga_safety":70,"aga_cost":62,"aga_keep":88},"facts":[{"label":"エビデンス（学会の推奨度）","text":"A","source":"日本皮膚科学会GL2017：推奨度A"}],"sources":{"aga_evidence":"日本皮膚科学会GL2017：推奨度A","aga_efficacy":"editorial: 還元酵素のI型とII型の両方を阻害する仕組みの内服薬で、この軸はフィナステリドより上の上位のため高め（2026-06初評）","aga_safety":"editorial: 二つの型の酵素を阻害する分だけ作用の範囲が広い内服薬で、フィナステリドのすぐ下のためやや高め（2026-06初評）","aga_cost":"editorial: 毎日飲み続ける内服薬でフィナステリドより薬代が張りやすく、費用の軽さは候補の中ほどのためやや高め（2026-06初評）","aga_keep":"editorial: 一日一回の内服で塗る手間も通院の頻度も小さく、フィナステリドと同点の上位のため高め（2026-06初評）"}},{"id":"aga_minox_top","name":"ミノキシジル外用（5%）","name_en":null,"provider":"外用薬","jurisdiction":"日本","note":"頭皮に塗る発毛剤。血流や毛包への作用で発毛を促す。推奨度A（男性5%・女性1%）。市販あり。","note_en":null,"url":"https://www.jstage.jst.go.jp/article/dermatol/127/13/127_2763/_article/-char/ja/","shop_url":null,"metrics":{"aga_evidence":95,"aga_efficacy":70,"aga_safety":80,"aga_cost":70,"aga_keep":58},"facts":[{"label":"エビデンス（学会の推奨度）","text":"A","source":"日本皮膚科学会GL2017：推奨度A（男性5%）"}],"sources":{"aga_evidence":"日本皮膚科学会GL2017：推奨度A（男性5%）","aga_efficacy":"editorial: 頭皮に塗って毛包に働きかける仕組みで作用が塗った範囲に限られ、候補の中ほどのためやや高め（2026-06初評）","aga_safety":"editorial: 塗った部位に作用がとどまる外用薬で全身への影響が内服より小さく、この軸は候補上位のため高め（2026-06初評）","aga_cost":"editorial: 市販でも手に入る外用薬で通院費をかけずに続けられ、費用の軽さは候補上位のためやや高め（2026-06初評）","aga_keep":"editorial: 毎日頭皮に塗る手間と乾くまでの待ち時間があり、続けやすさは内服薬より下の中ほどのため中位（2026-06初評）"}},{"id":"aga_transplant","name":"自毛植毛","name_en":null,"provider":"外科治療","jurisdiction":"日本","note":"後頭部などの自分の毛を薄い部位へ移植。定着すれば半永久的。男性の推奨度B。高額。","note_en":null,"url":"https://www.jstage.jst.go.jp/article/dermatol/127/13/127_2763/_article/-char/ja/","shop_url":null,"metrics":{"aga_evidence":75,"aga_efficacy":88,"aga_safety":62,"aga_cost":22,"aga_keep":95},"facts":[{"label":"エビデンス（学会の推奨度）","text":"B","source":"日本皮膚科学会GL2017：推奨度B（男性）"}],"sources":{"aga_evidence":"日本皮膚科学会GL2017：推奨度B（男性）","aga_efficacy":"editorial: 自分の毛を薄い部位へ移し定着すれば半永久的に残る仕組みで、この軸は候補8つで最上位のため高め（2026-06初評）","aga_safety":"editorial: 外科手術のため術後の腫れや傷あとなど手術に伴う負担があり、この軸は候補下位のため中位（2026-06初評）","aga_cost":"editorial: 外科手術で移植する量に応じて総額が膨らむ高額な自由診療で、候補で最下位の同点のため低め（2026-06初評）","aga_keep":"editorial: 手術が済み定着すれば日々の服薬や塗布が要らない型で、続ける手間は候補で最も小さいため高め（2026-06初評）"}},{"id":"aga_lllt","name":"LED・低出力レーザー照射","name_en":null,"provider":"機器治療","jurisdiction":"日本","note":"低出力の光・レーザーを頭皮に当てる治療。推奨度B（ただしエビデンスは限定的）。","note_en":null,"url":"https://www.jstage.jst.go.jp/article/dermatol/127/13/127_2763/_article/-char/ja/","shop_url":null,"metrics":{"aga_evidence":72,"aga_efficacy":50,"aga_safety":88,"aga_cost":45,"aga_keep":55},"facts":[{"label":"エビデンス（学会の推奨度）","text":"B","source":"日本皮膚科学会GL2017：推奨度B（エビデンス限定的）"}],"sources":{"aga_evidence":"日本皮膚科学会GL2017：推奨度B（エビデンス限定的）","aga_efficacy":"editorial: 低出力の光を頭皮に当てる仕組みで、根拠が限定的とされる分この軸は候補下位のため中位（2026-06初評）","aga_safety":"editorial: 薬を使わず低出力の光を当てるだけで体内への作用が小さく、この軸はかつらに次ぐ上位のため高め（2026-06初評）","aga_cost":"editorial: 機器の購入か通院での照射が必要で最初の負担が大きく、費用の軽さは候補下位のため中位の下（2026-06初評）","aga_keep":"editorial: 決まった頻度で照射の時間を取り続ける必要があり、続けやすさは候補8つの下位のため中位（2026-06初評）"}},{"id":"aga_minox_oral","name":"ミノキシジル内服","name_en":null,"provider":"内服薬（適応外）","jurisdiction":"日本","note":"飲むミノキシジル。発毛効果はあるが循環器系副作用の懸念があり、ガイドラインの推奨度D（行うべきでない）。","note_en":null,"url":"https://www.jstage.jst.go.jp/article/dermatol/127/13/127_2763/_article/-char/ja/","shop_url":null,"metrics":{"aga_evidence":15,"aga_efficacy":80,"aga_safety":30,"aga_cost":65,"aga_keep":82},"facts":[{"label":"エビデンス（学会の推奨度）","text":"D","source":"日本皮膚科学会GL2017：推奨度D（行うべきでない）"}],"sources":{"aga_evidence":"日本皮膚科学会GL2017：推奨度D（行うべきでない）","aga_efficacy":"editorial: 成分を内服で全身から届ける仕組みだが適応外の使い方にあたり、この軸の位置は候補上位のため高め（2026-06初評）","aga_safety":"editorial: 循環器系の副作用の懸念から学会の推奨度が最も低い適応外の内服で、候補で最下位のため低め（2026-06初評）","aga_cost":"editorial: 内服薬で一回の負担は小さいが適応外のため処方の経路が限られ、候補の中ほどのためやや高め（2026-06初評）","aga_keep":"editorial: 飲むだけで手間は小さいが適応外で処方先が限られ体調の確認も要り、内服薬の中では下のため高め（2026-06初評）"}},{"id":"aga_meso","name":"メソセラピー・成長因子・幹細胞","name_en":null,"provider":"注入治療","jurisdiction":"日本","note":"頭皮へ成長因子等を注入する自由診療。成長因子導入・細胞移植は推奨度C2（行わないほうがよい）。","note_en":null,"url":"https://www.jstage.jst.go.jp/article/dermatol/127/13/127_2763/_article/-char/ja/","shop_url":null,"metrics":{"aga_evidence":35,"aga_efficacy":50,"aga_safety":60,"aga_cost":22,"aga_keep":50},"facts":[{"label":"エビデンス（学会の推奨度）","text":"C2","source":"日本皮膚科学会GL2017：成長因子導入/細胞移植は推奨度C2"}],"sources":{"aga_evidence":"日本皮膚科学会GL2017：成長因子導入/細胞移植は推奨度C2","aga_efficacy":"editorial: 成長因子などを頭皮に注入する仕組みだが学会の推奨度が低く、この軸は候補下位の同点のため中位（2026-06初評）","aga_safety":"editorial: 頭皮へ針で注入する自由診療で手技や製剤が施設ごとに異なり、この軸は候補下位のため中位（2026-06初評）","aga_cost":"editorial: 自由診療の注入を回数を重ねて受ける形で総額が大きくなりやすく、最下位の同点のため低め（2026-06初評）","aga_keep":"editorial: 注入のたびに通院が必要で回数も重なり、生活への組み込みやすさは候補で最下位のため中位（2026-06初評）"}},{"id":"aga_wig","name":"かつら・ウィッグ・増毛","name_en":null,"provider":"非治療","jurisdiction":"日本","note":"髪を増やすのではなく隠す手段。推奨度C1（行ってもよい）。発毛効果はない。","note_en":null,"url":"https://www.jstage.jst.go.jp/article/dermatol/127/13/127_2763/_article/-char/ja/","shop_url":null,"metrics":{"aga_evidence":55,"aga_efficacy":40,"aga_safety":90,"aga_cost":50,"aga_keep":60},"facts":[{"label":"エビデンス（学会の推奨度）","text":"C1","source":"日本皮膚科学会GL2017：かつらの着用は推奨度C1"}],"sources":{"aga_evidence":"日本皮膚科学会GL2017：かつらの着用は推奨度C1","aga_efficacy":"editorial: 髪を増やすのでなく隠す手段で発毛の作用そのものは持たず、この軸は候補で最下位のため低め（2026-06初評）","aga_safety":"editorial: 体に薬を入れず頭皮の上に着けるだけの非治療の手段で、この軸は候補8つで最上位のため高め（2026-06初評）","aga_cost":"editorial: 薬代は無いが製作費に加えて手入れや作り替えの費用が続き、費用の軽さは候補の中ほどのため中位（2026-06初評）","aga_keep":"editorial: 通院は要らないが毎日の着脱と手入れ、定期的な調整が続き、続けやすさは候補の中ほどのため中位（2026-06初評）"}}],"profiles":[{"id":"aga_standard","name":"まず標準治療から","name_en":"Start with standard care","weights":{"aga_evidence":0.35,"aga_efficacy":0.25,"aga_safety":0.15,"aga_cost":0.1,"aga_keep":0.15}},{"id":"aga_maxgrowth","name":"発毛を最大化したい","name_en":"Maximize regrowth","weights":{"aga_evidence":0.25000000000000006,"aga_efficacy":0.45000000000000007,"aga_safety":0.10000000000000002,"aga_cost":0.10000000000000002,"aga_keep":0.10000000000000002}},{"id":"aga_safetyfirst","name":"副作用が心配","name_en":"Safety first","weights":{"aga_evidence":0.25,"aga_efficacy":0.15,"aga_safety":0.4,"aga_cost":0.1,"aga_keep":0.1}},{"id":"aga_budget","name":"費用を抑えたい","name_en":"Budget-conscious","weights":{"aga_evidence":0.2,"aga_efficacy":0.15,"aga_safety":0.1,"aga_cost":0.4,"aga_keep":0.15}},{"id":"aga_lowburden","name":"手軽に続けたい","name_en":"Low burden","weights":{"aga_evidence":0.15,"aga_efficacy":0.2,"aga_safety":0.15,"aga_cost":0.1,"aga_keep":0.4}}],"articles":[{"slug":"aga-chiryo-choose-2026","title":"AGA治療の違いは「守る」か「増やす」か——フィナステリドとミノキシジルは役割が逆","dek":"同じAGA治療薬でも、抜け毛を止める薬と、生やす薬は仕組みが別。この2つの役割を分けて理解すると、費用と効果の見通しが立つ。"},{"slug":"choose-aga-treatment-2026","title":"AGA治療の選び方：学会の「推奨度」で選ぶ","dek":"広告だらけのAGA。日本皮膚科学会が科学的根拠で格付けした「推奨度A〜D」を地図にすれば、迷いはぐっと減る。"}],"terms":[{"slug":"agaguideline","term":"AGA診療ガイドライン","short_def":"日本皮膚科学会が公表する脱毛症診療の指針。治療法ごとの推奨を整理した文書で、クリニック広告を読むときの物差しになる。"}],"campaigns":[]}